BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22583733)

  • 1. Galli-Galli disease is an acantholytic variant of Dowling-Degos disease: additional genetic evidence in a German family.
    Schmieder A; Pasternack SM; Krahl D; Betz RC; Leverkus M
    J Am Acad Dermatol; 2012 Jun; 66(6):e250-1. PubMed ID: 22583733
    [No Abstract]   [Full Text] [Related]  

  • 2. Galli-Galli disease is an acantholytic variant of Dowling-Degos disease.
    Sprecher E; Indelman M; Khamaysi Z; Lugassy J; Petronius D; Bergman R
    Br J Dermatol; 2007 Mar; 156(3):572-4. PubMed ID: 17300252
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease.
    Hanneken S; Rütten A; Pasternack SM; Eigelshoven S; El Shabrawi-Caelen L; Wenzel J; Braun-Falco M; Ruzicka T; Nöthen MM; Kruse R; Betz RC
    Br J Dermatol; 2010 Jul; 163(1):197-200. PubMed ID: 20222933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding spectrum of Galli-Galli disease.
    El Shabrawi-Caelen L; Rütten A; Kerl H
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S86-91. PubMed ID: 17434047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].
    Hanneken S; Rütten A; Eigelshoven S; Braun-Falco M; Pasternack SM; Ruzicka T; Nöthen MM; Betz RC; Kruse R
    Hautarzt; 2011 Nov; 62(11):842-51. PubMed ID: 21971768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?
    Braun-Falco M; Volgger W; Borelli S; Ring J; Disch R
    J Am Acad Dermatol; 2001 Nov; 45(5):760-3. PubMed ID: 11606930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Galli-Galli disease. Review of the literature].
    Hautarzt; 2013 Apr; 64(4):282. PubMed ID: 23553204
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized Dowling-Degos disease.
    Wu YH; Lin YC
    J Am Acad Dermatol; 2007 Aug; 57(2):327-34. PubMed ID: 17637446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Galli-Galli disease presenting as lichenoid papules in the flexures].
    García-Salces I; Hörndler C; Requena L
    Actas Dermosifiliogr; 2010 Mar; 101(2):168-72. PubMed ID: 20223160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease.
    Reisenauer AK; Wordingham SV; York J; Kokkonen EW; Mclean WH; Wilson NJ; Smith FJ
    Br J Dermatol; 2014 Jun; 170(6):1362-5. PubMed ID: 24372084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galli-Galli disease: A case report with review of the literature.
    Gilchrist H; Jackson S; Morse L; Nicotri T; Nesbitt LT
    J Am Acad Dermatol; 2008 Feb; 58(2):299-302. PubMed ID: 18222327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of the role of a KRT5 mutation and successful management of skin lesions in a patient with Galli-Galli disease.
    Lőrincz K; Medvecz M; Kiss N; Glász-Bóna A; Hársing J; Lepesi-Benkő R; Hatvani Z; Mazán M; Kárpáti S; Wikonkál N
    Clin Exp Dermatol; 2018 Dec; 43(8):972-974. PubMed ID: 29882260
    [No Abstract]   [Full Text] [Related]  

  • 13. Dowling-Degos disease: a review.
    Stephan C; Kurban M; Abbas O
    Int J Dermatol; 2021 Aug; 60(8):944-950. PubMed ID: 33368260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 segmental Galli-Galli disease resulting from a previously unreported keratin 5 mutation.
    Arnold AW; Kiritsi D; Happle R; Kohlhase J; Hausser I; Bruckner-Tuderman L; Has C; Itin PH
    J Invest Dermatol; 2012 Aug; 132(8):2100-3. PubMed ID: 22437315
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical variant of galli-galli disease (grover-like eruption with lentiginous freckling) in a liver transplant patient.
    Rongioletti F; Fausti V; Christana K; Montinari M; Parodi A; Fiocca R
    Am J Dermatopathol; 2011 Jul; 33(5):504-7. PubMed ID: 21252638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haber's syndrome may be a clinical entity different from Dowling-Degos disease.
    Nishizawa A; Nakano H; Satoh T; Takayama K; Sawamura D; Yokozeki H
    Br J Dermatol; 2009 Jan; 160(1):215-7. PubMed ID: 19067693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease?].
    Bardach H; Gebhart W; Luger T
    Hautarzt; 1982 Jul; 33(7):378-83. PubMed ID: 7107282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated papular variant of Dowling-Degos disease: Histopathological features in POGLUT1 mutation.
    Papadopoulou K; Karsai S; Böer-Auer A
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1423-1429. PubMed ID: 36314591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dowling-Degos disease involving the vulva and back: case report and review of the literature.
    Horner ME; Parkinson KE; Kaye V; Lynch PJ
    Dermatol Online J; 2011 Jul; 17(7):1. PubMed ID: 21810386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.
    Verma S; Pasternack SM; Rütten A; Ruzicka T; Betz RC; Hanneken S
    Indian J Dermatol; 2014 Sep; 59(5):476-80. PubMed ID: 25284854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.